ITIH3 and colorectal carcinoma: In the present study, we showed for the first time that the plasma concentrations of ITIH3 are significantly decreased in CRC patients relative to normal controls (p < 0.001), consistent with ITIH3 mRNA expression patterns in tissues of multiple solid cancer types, such as breast, uterus, colon, ovary, lung, and rectum cancers [11].